Culture Medium (UPIN) Stock Price, News & Analysis

Company Overview

Culture Medium (OTCMKTS:UPIN) is a life sciences company focused on the development, manufacture and distribution of advanced cell culture media, reagents and laboratory consumables. Its core offerings include basal and enriched media formulations, serum replacements, growth supplements and custom media designed to support cell line development, drug discovery and regenerative medicine applications. The company also provides ancillary products such as cultureware, cryopreservation solutions and quality control assays to help researchers optimize experimental workflows.

Since its founding in 2008, Culture Medium has expanded its footprint through the establishment of manufacturing facilities in North America, Europe and Asia-Pacific. The company operates cGMP-compliant production sites and holds ISO 9001 and ISO 13485 certifications, enabling it to serve a diverse customer base that includes academic institutions, contract research organizations and multinational pharmaceutical firms. In 2015, Culture Medium completed a reverse merger and began trading on the OTC Markets under the symbol UPIN.

Headquartered in Boston, Massachusetts, Culture Medium is led by CEO Mark Reynolds, who has more than 20 years of experience in life sciences manufacturing, and CFO Sarah Patel, a veteran finance executive in the biotech sector. The management team is supported by a board of directors that brings expertise in cell biology, regulatory affairs and global supply-chain management. Together, they steer the company’s strategic initiatives in product innovation and market expansion.

Building on its research-driven heritage, Culture Medium actively collaborates with leading universities, biotech startups and contract development organizations to develop next-generation media tailored for stem cell, organoid and immuno-oncology applications. The company continues to invest in R&D partnerships, regulatory compliance and production scale-up to address evolving customer needs in personalized medicine and biologics manufacturing.

Key Stats

• Today's Range: $0.0010 to $0.0010
• 50-Day Range: N/A
• 52-Week Range: $0.0010 to $0.01
• Volume: N/A
• Average Volume: 3,000 shs
• Market Capitalization: $56.18 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

UPIN Stock Analysis - Frequently Asked Questions

How have UPIN shares performed this year?

Culture Medium's stock was trading at $0.01 on January 1st, 2025. Since then, UPIN stock has decreased by 90.0% and is now trading at $0.0010.

How do I buy shares of Culture Medium?

Shares of UPIN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Culture Medium own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Culture Medium investors own include Permian Resources (CDEV), 1PM Industries (OPMZ), Eaton (ETN), Cannabix Technologies (BLOZF) and Aurora Cannabis (ACB).

Company Calendar

• Today: 7/15/2025
• Fiscal Year End: 3/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Computer and Technology
• Industry: IT Services
• Sub-Industry: Precious Metals
• Current Symbol: OTCMKTS:UPIN
• CIK: N/A
• Web: www.upinholdings.com
• Phone: (800) 468-4102
• Fax: N/A
• Employees: 3
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 56,180,000
• Free Float: N/A
• Market Cap: $56.18 thousand
• Optionable: Not Optionable
• Beta: -0.91